AIDS-Related Lymphoma

We draw upon more than 30 years of experience in managing AIDS-related lymphoma, which can develop in people with untreated or advanced HIV. Our specialists use sophisticated diagnostic tools to develop personalized treatment plans for this cancer, which arises in white blood cells called lymphocytes. Treatments can include chemotherapy, targeted drugs, stem cell transplantation, or radiation therapy, combined with antiretroviral therapy. We can also determine whether new therapies offered through a clinical trial may be right for you.

Clinical Trials and Research Studies

Phase 1

A Phase 1 Study of TJ011133 Administered Alone or in Combination with Pembrolizumab or Rituximab in Subjects with Relapsed/Refractory Advanced Solid Tumors and Lymphoma

Learn More

Phase 2

Open-label Multicenter Phase 2 Study Evaluating the Efficacy & Safety of Daratumumab in Pediatric & Young Adult Subjects =1 & =30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Learn More

Phase 3

EA9161: A Randomized Phase III Study of the addition of Venetoclax to Ibrutinib and Obinutuzumab versus Ibrutinib and Obinutuzumab in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)

Learn More

Phase 2

NCI-COG PEDIATRIC MATCH (MOLECULAR ANALYSIS FOR THERAPY CHOICE)-PHASE 2 SUBPROTOCOL OF OLAPARIB IN PATIENTS WITH TUMORS HARBORING DEFECTS IN DNA DAMAGE REPAIR GENES

Learn More